Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 Clinical Trials in St Louis, Missouri

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma